Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Enteric Disease Testing Market Size, Share, & Trends Analysis Report by Disease (Bacterial, Viral, Parasitic), Region (North America, Europe, Asia Pacific, Latin America, MEA), with Growth Forecasts, 2025-2030" has been added to ResearchAndMarkets.com's offering.
The Enteric Disease Testing Market was valued at USD 3.96 Billion in 2024 and is projected to reach USD 4.74 Billion by 2030, rising at a CAGR of 3.10%.
The increasing incidence of enteric diseases and the adoption of advanced diagnostic technologies are key drivers of market growth. According to the U.S. Centers for Disease Control and Prevention, there are nearly 11 to 21 million cases of typhoid fever and approximately 5 million cases of paratyphoid fever recorded globally each year.
The rising incidence of gastrointestinal infections across various regions, influenced by changing lifestyles and consumer habits, has heightened demand for enteric disease testing solutions. Growing awareness of the severe effects of these diseases if untreated has resulted in an increased number of tests. Additionally, the focus of government agencies on safeguarding public health and preventing outbreaks is anticipated to further propel industry growth.
Government-led initiatives for enhanced healthcare, including screening programs and awareness campaigns, are set to stimulate market expansion. For example, in the U.S., the CDC employs the System for Enteric Disease Response, Investigation, and Coordination (SEDRIC) to ensure effective surveillance and response to food or animal contact-related disease outbreaks. The BEAM Dashboard, offering enteric disease outbreak data, exemplifies efforts to increase testing during the forecast period.
Enteric Disease Testing Market Report Highlights
- The bacterial segment led the market with nearly a 60% share in 2024, attributed to prevalent bacteria like C. difficile, E. coli, Shigella, and Salmonella causing common enteric diseases.
- The parasitic segment is poised for growth due to rising instances of enteric diseases linked to contaminated water and food, inadequate sanitation, and poor hygiene in several regions.
- Government emphasis on advanced healthcare services integrating cutting-edge diagnostic technologies is expected to generate growth opportunities.
- North America dominated the global market in 2024, driven by robust healthcare infrastructure and key diagnostic technology developers and biotechnology firms.
- Local agencies' preventative measures and government-funded research initiatives are expected to bolster growth.
- In February 2025, BIOMERIEUX announced U.S. FDA clearance for its new testing solution, BIOFIRE FILMARRAY Gastrointestinal (GI) Panel Mid.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into major regions and segments.
- Competitive Landscape: Explore the presence of key market players.
- Future Trends: Identify pivotal trends and drivers shaping the market's future.
- Actionable Recommendations: Leverage insights to discover new revenue streams and guide strategic decisions.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 100 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $3.96 Billion |
| Forecasted Market Value (USD) by 2030 | $4.74 Billion |
| Compound Annual Growth Rate | 3.1% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.5. Information or Data Analysis
- 1.6. Market Formulation & Validation
- 1.7. Model Details
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Enteric Diseases Testing Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.3. Enteric Diseases Testing Market Analysis Tools
Chapter 4. Enteric Diseases Testing: Disease Estimates & Trend Analysis
- 4.1. Disease Segment Dashboard
- 4.2. Industry Movement Analysis
- 4.3. Global Market Size & Trend Analysis, by Disease
Chapter 5. Enteric Diseases Testing Market: Regional Estimates & Trend Analysis
- 5.1. Regional Market Dashboard
- 5.2. Regional Market Share Analysis
- 5.3. Key Takeaways by Region
Chapter 6. Competitive Landscape
- 6.1. Recent Developments & Impact Analysis
- 6.2. Company/Competition Categorization
- 6.3. Vendor Landscape
- 6.4. Company Profiles
- Abbott
- BD
- Biomerica
- BIOMERIEUX
- Bio-Rad Laboratories, Inc.
- Cepheid
- Coris BioConcept
- DiaSorin S.p.A.
- Meridian Bioscience
- Quest Diagnostics Incorporated.
For more information about this report visit https://www.researchandmarkets.com/r/dvngyo
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
